Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3915179rdf:typepubmed:Citationlld:pubmed
pubmed-article:3915179lifeskim:mentionsumls-concept:C0579233lld:lifeskim
pubmed-article:3915179lifeskim:mentionsumls-concept:C0229671lld:lifeskim
pubmed-article:3915179lifeskim:mentionsumls-concept:C0011155lld:lifeskim
pubmed-article:3915179lifeskim:mentionsumls-concept:C0033452lld:lifeskim
pubmed-article:3915179lifeskim:mentionsumls-concept:C1159762lld:lifeskim
pubmed-article:3915179pubmed:issue6lld:pubmed
pubmed-article:3915179pubmed:dateCreated1986-7-10lld:pubmed
pubmed-article:3915179pubmed:abstractTextPhagocytic killing of group B streptococci serotypes Ia, Ib, IIR- (R protein negative), IIR+ (R protein positive), IIIR- and IIIR+ by human granulocytes was studied after opsonization in properdin deficient serum, pooled normal human serum and in selected sera with high or low concentrations of antibody to group B streptococci. All serotypes were killed by granulocytes after opsonization in normal serum, but serotype IIIR- was comparatively resistant. Properdin deficient serum showed no opsonic activity for type IIIR-. A reduced opsonic capacity of properdin deficient serum for serotypes Ib and IIR+ was demonstrated, whereas the other serotypes were efficiently opsonized. The reduced or absent opsonic activity of properdin deficient serum could be restored by addition of purified properdin. Antibody levels did not appear to be limiting in the assay system. Blocking of C1 activation with MgEGTA in normal serum delayed, but did not abolish opsonization of the various group B streptococcal serotypes, while the opsonic activity in chelated properdin deficient serum was markedly reduced. Taken together, the findings suggest that an intact classical pathway is crucial in group B streptococcal opsonization. However, efficient opsonization of some strains apparently requires that C3 activation on the bacterial surface is amplified through recruitment of the alternative pathway.lld:pubmed
pubmed-article:3915179pubmed:languageenglld:pubmed
pubmed-article:3915179pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3915179pubmed:citationSubsetIMlld:pubmed
pubmed-article:3915179pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3915179pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3915179pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3915179pubmed:statusMEDLINElld:pubmed
pubmed-article:3915179pubmed:monthDeclld:pubmed
pubmed-article:3915179pubmed:issn0108-0202lld:pubmed
pubmed-article:3915179pubmed:authorpubmed-author:ChristensenPPlld:pubmed
pubmed-article:3915179pubmed:authorpubmed-author:ChristensenK...lld:pubmed
pubmed-article:3915179pubmed:authorpubmed-author:BraconierJ...lld:pubmed
pubmed-article:3915179pubmed:authorpubmed-author:SjöholmA GAGlld:pubmed
pubmed-article:3915179pubmed:authorpubmed-author:SöderströmCClld:pubmed
pubmed-article:3915179pubmed:issnTypePrintlld:pubmed
pubmed-article:3915179pubmed:volume93lld:pubmed
pubmed-article:3915179pubmed:ownerNLMlld:pubmed
pubmed-article:3915179pubmed:authorsCompleteYlld:pubmed
pubmed-article:3915179pubmed:pagination251-6lld:pubmed
pubmed-article:3915179pubmed:dateRevised2009-6-4lld:pubmed
pubmed-article:3915179pubmed:meshHeadingpubmed-meshheading:3915179-...lld:pubmed
pubmed-article:3915179pubmed:meshHeadingpubmed-meshheading:3915179-...lld:pubmed
pubmed-article:3915179pubmed:meshHeadingpubmed-meshheading:3915179-...lld:pubmed
pubmed-article:3915179pubmed:meshHeadingpubmed-meshheading:3915179-...lld:pubmed
pubmed-article:3915179pubmed:meshHeadingpubmed-meshheading:3915179-...lld:pubmed
pubmed-article:3915179pubmed:meshHeadingpubmed-meshheading:3915179-...lld:pubmed
pubmed-article:3915179pubmed:meshHeadingpubmed-meshheading:3915179-...lld:pubmed
pubmed-article:3915179pubmed:meshHeadingpubmed-meshheading:3915179-...lld:pubmed
pubmed-article:3915179pubmed:meshHeadingpubmed-meshheading:3915179-...lld:pubmed
pubmed-article:3915179pubmed:meshHeadingpubmed-meshheading:3915179-...lld:pubmed
pubmed-article:3915179pubmed:meshHeadingpubmed-meshheading:3915179-...lld:pubmed
pubmed-article:3915179pubmed:meshHeadingpubmed-meshheading:3915179-...lld:pubmed
pubmed-article:3915179pubmed:year1985lld:pubmed
pubmed-article:3915179pubmed:articleTitleOpsonization of group B streptococci in properdin deficient serum.lld:pubmed
pubmed-article:3915179pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3915179pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:3915179pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3915179lld:pubmed